Company Overview and News

 
Red River Resources intersects high-grade gold and base metals between Liontown deposits

2018-09-11 proactiveinvestors.com.au
Red River Resources Ltd (ASX:RVR) has intersected high-grade gold, copper and zinc in drilling at the Liontown project within the company’s Thalanga Operations in northern Queensland.
RVR

 
Red River Resources valued at more than double the current price by Hartleys

2018-08-08 proactiveinvestors.com.au
Red River Resources Limited (ASX:RVR) has been maintained a Buy by Hartleys, with a 12-month price target of 61 cents per share, more than double the company’s current trading price of 24 cents.
RVR

 
Seaco containers efficiently guide miners from pit to port

2018-08-02 australianmining.com.au
The container leasing company has added value to various industries over the past 50 years. Now, it is targeting growth in this regard with mining companies. Australian Mining writes.
RVR

 
Seaco containers efficiently guide miners from pit to port

2018-07-23 australianmining.com.au
The container leasing company has added value to various industries over the past 50 years. Now, it is targeting growth in this regard with mining companies. Australian Mining writes.
RVR

 
Red River Resources reveals maiden JORC resource at Liontown East

2018-07-18 proactiveinvestors.com.au
Red River Resources Ltd (ASX:RVR) has revealed its maiden resource of 1.5 million tonnes grading 12.2% zinc equivalent at the Liontown East deposit within the Thalanga Project, Queensland.
RVR

 
Seaco containers efficiently guide miners from pit to port

2018-07-15 australianmining.com.au
The container leasing company has added value to various industries over the past 50 years. Now, it is targeting growth in this regard with mining companies. Australian Mining writes.
RVR

 
Red River awards PYBAR contract extension for West 45 mine

2018-07-13 australianmining.com.au
Red River Resources has awarded PYBAR Mining Services an extension to its contract for the West 45 underground zinc-lead mine.
RVR WSTC

 
Red River Resources extends West 45 mining contract, begins diamond drilling

2018-07-12 proactiveinvestors.com.au
Red River Resources Ltd (ASX:RVR) has awarded PYBAR Mining Services a two year extension to the underground mining contract at West 45 mine within the Thalanga zinc operation in North Queensland.
RVR

 
Red River Resources continues to improve production at Thalanga operation

2018-07-09 proactiveinvestors.com.au
Red River Resources Limited (ASX:RVR) has achieved improved operating performance from its Thalanga Operation in Northern Queensland during the June quarter.
RVR

 
Red River Resources moves forward with Far West development by awarding mining contract

2018-07-06 proactiveinvestors.com.au
Red River Resources Limited (ASX:RVR) has awarded a contract for underground mining at its Far West mine to PYBAR Mining Services.
RVR

 
Red River Resources has fund manager increase stake

2018-07-03 proactiveinvestors.com.au
Red River Resources Ltd (ASX:RVR) has had one of its major shareholders, Tribeca Investment Partners Pty Ltd, increase its stake in the company to 7.27% from 6.26%.
RVR

1
Red River Resources receives vote of confidence from Canaccord Genuity

2018-06-07 proactiveinvestors.com.au
Red River Resources Ltd (ASX:RVR) has hosted broker Canaccord Genuity on-site at its Thalanga Operations in Queensland.
SFRRF SNDFY SFR RVR

1
Red River Resources on track to develop Waterloo deposit with new high-grade drill results

2018-06-06 proactiveinvestors.com.au
Red River Resources Limited (ASX:RVR) is continuing to receive further positive results from drilling at the Waterloo polymetallic massive sulphide deposit, part of its Thalanga Operations in Queensland.
RVR

1
Red River Resources’ blast at Thalanga Far West sets the stage for underground development

2018-05-22 proactiveinvestors.com.au
Red River Resources Limited (ASX:RVR) has successfully completed the main blast at the Far West Box Cut site at its Thalanga Zinc Project in Central Queensland.
RVR

1
Red River awards contract to Pybar

2018-05-20 australianmining.com.au
Red River Resources has launched development of the Far West zinc project, which would be its second underground mine at Thalanga in central Queensland.
RVR

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:RVR / RED RIVER RESOURCES LIMITED on message board site Silicon Investor.

RVRLF Copper-Gold exploration Reservoir Minerals RVRLF Copper-Gold exploration Reservoir Minerals RVRLF Copper-Gold exploration Reservoir Minerals